2 for 2- 24/7 Market News Wrap 3 Jan 2024
DENVER, Colo., Jan. 3, 2024 (247marketnews.com)- 24/7 Market News covered the following companies today; ABVC BioPharma, Inc. (NASDAQ:ABVC), Neximmune Inc (NASDAQ:NEXI), Sidus Space Inc (NASDAQ:SIDU), Voyager Therapeutics Inc (NASDAQ:VYGR), and Cingulate (NASDAQ:CING).
Today makes it two for two, as low-float listings continue to dominate in 2024.
Our coverage, this morning, started with ABVC BioPharma’s (NASDAQ:ABVC) news that they received an aggregate of 46M shares from AiBtl BioPharma, valued at $460M, based on an independent third-party valuation report, when it was trading at $1.91, up $0.71 (+59.17%), on 9.8M shares traded. we covered it after it pulled back from what was its premarket high, $2.65, and it then set a new premarket high, $2.66, for this morning.
Unfortunately, ABVC didn’t trade as well in the regular trading session, as it maxed out at $2.46 and closed at $1.93, up $0.73 (+60.83%), on trading volume of 89M shares. This is one to keep on your screens for the next few months.
Next, we covered multiple low-float listings, which all provided solid upside moves, but none more than Neximmune (NASDAQ:NEXI). It already traded its reported 1.06M shares outstanding and 718.63K float shares multiple times, by the time we covered it this morning, when it was trading at $5.66, up $3.21 (+131.02%), on 4.29M shares.
Neximmune opened the regular session at $7.35 and trended higher, as it hit $10.97, just after lunch, before closing at $6.20, up $3.825 (+161.05%), on 61.4M shares traded.
Sidus Space (NASDAQ:SIDU) is shaping up to be an ideal post-split play, as its management is, so far, perfectly navigating the post-split waters. Today, Sidus Space announced that it secured NOAA approval to provide imaging services to government and commercial customers, which we included when it was trading at $8.56, up $1.59 (+22.81%), on 907.4K shares traded. It went on to top out at $13.48 and closed at $11.64, up $4.67 (+67.00%), on 15.1M shares traded.
After mentioning, in yesterday’s market wrap, that Voyager Therapeutics (NASDAQ:VYGR) disappointed, especially considering yesterday’s news and setup, because it seemed like it should have held more of yesterday’s gains. We covered Voyager Therapeutics, again, today, when it was trading at $10.10, up $1.10 (+12.22%), on 414.7K shares traded. It hit a high of $11.3497 and closed at $10.77, up $1.77 (+19.67%), on 3.7M shares traded.
Cingulate (NASDAQ:CING) is another low-float listing that we’ve been covering regularly and we reminded readers toay, when it was trading at $7.44, up $0.72 (+10.71%), on 354.5K shares traded. It hit a high of $8.90 and closed at $8.10, up $1.38 (+20.54%), on 902K shares traded.
CONTACT:
24/7 Market News
24/7 MARKET NEWS, INC Disclaimer
24/7 Market News (24/7MN) is a third-party publisher and online news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ, and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7 MN is not affiliated with any company written about in this release and owns no shares of stock. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable.
Few succeed in the stock market. Don’t trade if you’re not able to devote the necessary time. Earmark your surplus funds that you’re prepared to lose. Assess your risk appetite and set your stops accordingly, and honor your stop losses. Always employ loss limiting strategies. Be prepared to be blindsided by hidden risks, a bad company financing or other move can turn gains into losses.
Learn technical analysis, charting, patterns, and setups. Buying at the bottom and selling at the top is a myth. The middle half of a move is the sweet spot and learn how to exit a winning position, because trying to time the exact top can turn into big losses. Trade small and take advantage of small price move strategies, like scalping.
Remove emotional and psychological biases, and consider that you’re competing against professionals who’re deploying a number of powerful stock market tools. Successful traders make more on their winners than they lose on their losers. Learn how to interpret the ECN/Level 2 data.
The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.
Please go to 247marketnews.com or https://247marketnews.com/terms-disclaimer/ for further information.
Connect with 24/7 Market News:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.